Fenofibrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01039 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 34 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | homozygous familial hypercholesterolemia | KG + DL |
| 2 | hyperlipoproteinemia | KG + DL |
| 3 | familial hypercholesterolemia | KG + DL |
| 4 | cholesterol-ester transfer protein deficiency | KG + DL |
| 5 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | KG + DL |
| 6 | hyperlipidemia due to hepatic triglyceride lipase deficiency | KG + DL |
| 7 | hypercholesterolemia, autosomal dominant | KG + DL |
| 8 | hypolipoproteinemia (disease) | KG + DL |
| 9 | hyperalphalipoproteinemia | KG + DL |
| 10 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 11 | HIV infectious disease | KG + DL |
| 12 | sitosterolemia | KG + DL |
| 13 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 14 | obsolete susceptibility to ischemic stroke | KG + DL |
| 15 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 16 | hypertriglyceridemia, familial | KG + DL |
| 17 | familial chylomicronemia syndrome | KG + DL |
| 18 | feline acquired immunodeficiency syndrome | KG + DL |
| 19 | simian immunodeficiency virus infection | KG + DL |
| 20 | diabetic nephropathy | KG + DL |
| 21 | hepatoportal sclerosis | KG + DL |
| 22 | primitive portal vein thrombosis | KG + DL |
| 23 | early-onset familial noncirrhotic portal hypertension | KG + DL |
| 24 | idiopathic copper-associated cirrhosis | KG + DL |
| 25 | hepatopulmonary syndrome | KG + DL |
| 26 | hepatic porphyria | KG + DL |
| 27 | fish eye disease | KG + DL |
| 28 | brain stem infarction | KG + DL |
| 29 | congestive heart failure | KG + DL |
| 30 | fibroma of prostate | KG + DL |
| 31 | familial hypobetalipoproteinemia | KG + DL |
| 32 | acute pulmonary heart disease | KG + DL |
| 33 | Norum disease | KG + DL |
| 34 | benign reproductive system neoplasm | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.